Denian Wang

502 total citations
30 papers, 345 citations indexed

About

Denian Wang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Denian Wang has authored 30 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Denian Wang's work include Neuropeptides and Animal Physiology (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Receptor Mechanisms and Signaling (4 papers). Denian Wang is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Receptor Mechanisms and Signaling (4 papers). Denian Wang collaborates with scholars based in China. Denian Wang's co-authors include Zixuan Zhan, Yonggang Wei, Weimin Li, Yi Lv, Yong-Cheng Dai, Wei Zhang, Li Chai, Min Li, Fei Xiao and Hongyu Li and has published in prestigious journals such as Nature Communications, Analytical Chemistry and Scientific Reports.

In The Last Decade

Denian Wang

28 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denian Wang China 10 160 70 60 52 48 30 345
Karolina Dzwonek Poland 11 160 1.0× 32 0.5× 61 1.0× 18 0.3× 54 1.1× 23 355
Karen Aughton United Kingdom 10 215 1.3× 35 0.5× 54 0.9× 28 0.5× 33 0.7× 15 397
Joseph F. Rhoderick United States 10 300 1.9× 111 1.6× 67 1.1× 179 3.4× 75 1.6× 19 567
Gabriel Kuteyi United Kingdom 5 236 1.5× 90 1.3× 20 0.3× 44 0.8× 92 1.9× 6 377
Asghar Hajibeigi United States 12 147 0.9× 65 0.9× 26 0.4× 22 0.4× 37 0.8× 16 477
Ryuichi Nishigaki Japan 10 279 1.7× 38 0.5× 22 0.4× 22 0.4× 22 0.5× 12 412
Lyndsay E.A. Young United States 13 362 2.3× 31 0.4× 32 0.5× 24 0.5× 29 0.6× 38 585
Cynthia Ng Australia 5 238 1.5× 64 0.9× 23 0.4× 162 3.1× 37 0.8× 8 414
Imane Nafia France 10 70 0.4× 66 0.9× 54 0.9× 17 0.3× 32 0.7× 12 255
Md Nabiul Hasan United States 14 232 1.4× 59 0.8× 129 2.1× 9 0.2× 22 0.5× 17 596

Countries citing papers authored by Denian Wang

Since Specialization
Citations

This map shows the geographic impact of Denian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denian Wang more than expected).

Fields of papers citing papers by Denian Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denian Wang. The network helps show where Denian Wang may publish in the future.

Co-authorship network of co-authors of Denian Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Denian Wang. A scholar is included among the top collaborators of Denian Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denian Wang. Denian Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Denian, Lijuan He, Ke Yuan, et al.. (2025). Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics. Communications Biology. 8(1). 804–804. 2 indexed citations
3.
Li, Yuepeng, Xiaolong Tang, Rui Zhang, et al.. (2025). Research progress in early states of chronic obstructive pulmonary disease: a narrative review on PRISm, pre-COPD, young COPD and mild COPD. Expert Review of Respiratory Medicine. 19(10). 1063–1079. 1 indexed citations
4.
Wang, Denian, Zhi Yang, Pengfei Wu, et al.. (2025). Adrenomedullin 2 attenuates anxiety-like behaviors by increasing IGF-II in amygdala and re-establishing blood–brain barrier. Translational Psychiatry. 15(1). 10–10. 2 indexed citations
5.
Wang, Denian, Chunyan Yu, Rui Zhang, et al.. (2024). Accurate diagnosis of early-stage lung cancer by targeting lipid droplets with a two-photon near-infrared fluorescence probe. Sensors and Actuators B Chemical. 426. 137023–137023. 6 indexed citations
6.
Zheng, Yalin, et al.. (2024). Exosomal Proteomics: Unveiling Novel Insights into Lung Cancer. Aging and Disease. 16(2). 876–900. 11 indexed citations
7.
Pu, Yaoyu, et al.. (2023). Multimode evaluating the fluctuation of lipid droplets polarity in acute kidney injury and tumor models. Sensors and Actuators B Chemical. 380. 133343–133343. 23 indexed citations
8.
Song, Wenpeng, Denian Wang, Yan Wang, et al.. (2023). Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis. World Journal of Surgical Oncology. 21(1). 190–190. 4 indexed citations
9.
Zhang, Rui, Ying Wei, Denian Wang, et al.. (2023). Deep learning for malignancy risk estimation of incidental sub-centimeter pulmonary nodules on CT images. European Radiology. 34(7). 4218–4229. 13 indexed citations
10.
Wang, Jing, Yifei Lin, Denian Wang, et al.. (2023). Metatranscriptomic analysis revealed Prevotella as a potential biomarker of oropharyngeal microbiomes in SARS-CoV-2 infection. Frontiers in Cellular and Infection Microbiology. 13. 1161763–1161763. 5 indexed citations
11.
Yang, Zhi, Hongchun Li, Pengfei Wu, et al.. (2023). Multi-biological functions of intermedin in diseases. Frontiers in Physiology. 14. 1233073–1233073. 4 indexed citations
12.
Hu, Yanjia, Hao Liu, Xin Qi, et al.. (2022). LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway. Biochemical and Biophysical Research Communications. 629. 17–25. 8 indexed citations
13.
Fu, Yang, Denian Wang, Shuang Wang, et al.. (2021). Blockade of macrophage-associated programmed death 1 inhibits the pyroptosis signalling pathway in sepsis. Inflammation Research. 70(9). 993–1004. 12 indexed citations
14.
Xiao, Fei, Hongyu Li, Lüping Huang, et al.. (2021). Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade. Scientific Reports. 11(1). 488–488. 9 indexed citations
15.
Huang, Lüping, Denian Wang, Huan Zhao, et al.. (2020). Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide. Molecular Cancer Therapeutics. 20(2). 284–295. 7 indexed citations
16.
Wang, Denian, Fei Xiao, Min Li, et al.. (2020). Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence. Breast Cancer Research. 22(1). 44 indexed citations
17.
Xiao, Fei, Denian Wang, Min Li, et al.. (2018). Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses. Nature Communications. 9(1). 2644–2644. 49 indexed citations
18.
Yang, Jing, Cheng Li, Jing Zhang, et al.. (2018). Predictive value of circulating cell-free DNA in the survival of breast cancer patients. Medicine. 97(28). e11417–e11417. 11 indexed citations
19.
Wang, Denian, Fei Xiao, Lan Zou, et al.. (2017). The “inherent vice” in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively. Scientific Reports. 7(1). 2365–2365. 6 indexed citations
20.
Xiao, Fei, Lijun Wang, Huan Zhao, et al.. (2015). Intermedin restricts vessel sprouting by inhibiting the loosening of endothelial junction. Biochemical and Biophysical Research Communications. 458(1). 174–179. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026